Literature DB >> 2890534

Nephropathia epidemica: incidence of clinical cases and antibody prevalence in an endemic area of Sweden.

B Niklasson1, J Leduc, K Nyström, L Nyman.   

Abstract

The incidence of nephropathia epidemica (NE) was compared with the NE antibody prevalence in normal population in a highly endemic area of Sweden (Västerbotten county). The antibody prevalence rate in the oldest age groups were found to be 14 and 20 times higher than the accumulated life-risk of being hospitalized with NE for men and women respectively. Whether the infection in persons not admitted to hospital is subclinical, atypical or clinically fulminant, remains to be determined.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2890534      PMCID： PMC2249286          DOI： 10.1017/s0950268800068060

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN： 0950-2688            Impact factor:   2.451


  2 in total

1.  Isolation of the nephropathia epidemica agent in Sweden.

Authors:  B Niklasson; J Le Duc
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

2.  Epidemiology of nephropathia epidemica in Sweden.

Authors:  B Niklasson; J W LeDuc
Journal:  J Infect Dis       Date:  1987-02       Impact factor: 5.226
  2 in total
  9 in total

1.  Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; T Kjelsson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

Review 2.  The hantaviruses of Europe: from the bedside to the bench.

Authors:  J Clement; P Heyman; P McKenna; P Colson; T Avsic-Zupanc
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

3.  Seroepidemiological study in a Puumala virus outbreak area in South-East Germany.

Authors:  Marc Mertens; Roman Wölfel; Katrin Ullrich; Kumiko Yoshimatsu; Jana Blumhardt; Ina Römer; Jutta Esser; Jonas Schmidt-Chanasit; Martin H Groschup; Gerhard Dobler; Sandra S Essbauer; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2009-01-16       Impact factor: 3.402

4.  Hemorrhagic fever with renal syndrome: a study of sequelae following nephropathia epidemica.

Authors:  B Niklasson; G Hellsten; J LeDuc
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 5.  Haemorrhagic fever with renal syndrome, virological and epidemiological aspects.

Authors:  B S Niklasson
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

6.  Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden.

Authors:  C Ahlm; M Linderholm; P Juto; B Stegmayr; B Settergren
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

7.  Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans.

Authors:  A Lundkvist; S Björsten; B Niklasson; N Ahlborg
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Concomitant leptospirosis-hantavirus co-infection in acute patients hospitalized in Sri Lanka: implications for a potentially worldwide underestimated problem.

Authors:  N P Sunil-Chandra; J Clement; P Maes; H J DE Silva; M VAN Esbroeck; M VAN Ranst
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

9.  Human hantavirus infections, Sweden.

Authors:  Gert E Olsson; Fredrik Dalerum; Birger Hörnfeldt; Fredrik Elgh; Thomas R Palo; Per Juto; Clas Ahlm
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.